Recent Posts

• Genmab and UiO: Aiming to use artificial intelligence to develop new therapeutics
• Summary of the year 2023
• Meet Inven2 at the Nordic Life Science Days
• Licensing validates Norwegian platform technology for the development of tailored monoclonal antibodies
• Authera lands collaborative agreement with argenx